Yüklüyor......
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
Endothelin receptor antagonism has emerged as an important therapeutic approach in pulmonary arterial hypertension (PAH). Bench to bedside scientific research has shown that endothelin-1 (ET-1) is overexpressed in several forms of pulmonary vascular disease and may play an important pathogenetic rol...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2605321/ https://ncbi.nlm.nih.gov/pubmed/19183742 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|